LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent

  1. Daniela PUZZO
  2. Roberto Piacentini
  3. Mauro Fa'
  4. Walter Gulisano
  5. Domenica D Li Puma
  6. Agnes Staniszewski
  7. Hong Zhang
  8. Maria Rosaria Tropea
  9. Sara Cocco
  10. Agostino Palmeri
  11. Paul Fraser
  12. Luciano D'Adamio
  13. Claudio Grassi
  14. Ottavio Arancio  Is a corresponding author
  1. University of Catania, Italy
  2. Università Cattolica del Sacro Cuore, Italy
  3. Columbia University, United States
  4. University of Toronto, Canada
  5. Albert Einstein College of Medicine, United States

Abstract

The concurrent application of subtoxic doses of soluble oligomeric forms of human amyloid-beta (oAβ) and Tau (oTau) proteins impairs memory and its electrophysiological surrogate long-term potentiation (LTP), effects that may be mediated by intra-neuronal oligomers uptake. Intrigued by these findings, we investigated whether oAβ and oTau share a common mechanism when they impair memory and LTP in mice. We found that as already shown for oAβ, also oTau can bind to amyloid precursor protein (APP). Moreover, efficient intra-neuronal uptake of oAβ and oTau requires expression of APP. Finally, the toxic effect of both extracellular oAβ and oTau on memory and LTP is dependent upon APP since APP-KO mice were resistant to oAβ- and oTau-induced defects in spatial/associative memory and LTP. Thus, APP might serve as a common therapeutic target against Alzheimer’s Disease (AD) and a host of other neurodegenerative diseases characterized by abnormal levels of Aβ and/or Tau.

Article and author information

Author details

  1. Daniela PUZZO

    Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9542-2251
  2. Roberto Piacentini

    Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
    Competing interests
    The authors declare that no competing interests exist.
  3. Mauro Fa'

    Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Walter Gulisano

    Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
    Competing interests
    The authors declare that no competing interests exist.
  5. Domenica D Li Puma

    Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
    Competing interests
    The authors declare that no competing interests exist.
  6. Agnes Staniszewski

    Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Hong Zhang

    Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Maria Rosaria Tropea

    Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
    Competing interests
    The authors declare that no competing interests exist.
  9. Sara Cocco

    Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
    Competing interests
    The authors declare that no competing interests exist.
  10. Agostino Palmeri

    Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
    Competing interests
    The authors declare that no competing interests exist.
  11. Paul Fraser

    Tanz Centre for Research in Neurodegenerative Diseases and Department of Medical Biophysics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  12. Luciano D'Adamio

    Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Claudio Grassi

    Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7253-1685
  14. Ottavio Arancio

    Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New york, United States
    For correspondence
    oa1@columbia.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6335-164X

Funding

National Institutes of Health (R01AG049402)

  • Ottavio Arancio

Italian FFO

  • Daniela PUZZO

Canadian Institutes of Health Research

  • Paul Fraser

Catholic University Intramural Funds

  • Claudio Grassi

Italian FFO

  • Agostino Palmeri

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Alison Goate, Icahn School of Medicine at Mount Sinai, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and the European Community Council. All protocols involving animals were approved by Columbia University (#AC-AAAO5301), Università di Catania (#327/2013-B, #119-2017-PR), Università Cattolica del Sacro Cuore (#626-2016-PR), Albert Einstein College of Medicine (#20160407), and the respective Institutional Animal care and Use Committee (IACUC).

Version history

  1. Received: March 20, 2017
  2. Accepted: July 10, 2017
  3. Accepted Manuscript published: July 11, 2017 (version 1)
  4. Version of Record published: July 26, 2017 (version 2)

Copyright

© 2017, PUZZO et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,272
    views
  • 784
    downloads
  • 119
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Daniela PUZZO
  2. Roberto Piacentini
  3. Mauro Fa'
  4. Walter Gulisano
  5. Domenica D Li Puma
  6. Agnes Staniszewski
  7. Hong Zhang
  8. Maria Rosaria Tropea
  9. Sara Cocco
  10. Agostino Palmeri
  11. Paul Fraser
  12. Luciano D'Adamio
  13. Claudio Grassi
  14. Ottavio Arancio
(2017)
LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
eLife 6:e26991.
https://doi.org/10.7554/eLife.26991

Share this article

https://doi.org/10.7554/eLife.26991

Further reading

    1. Neuroscience
    James Malkin, Cian O'Donnell ... Laurence Aitchison
    Research Article

    Biological synaptic transmission is unreliable, and this unreliability likely degrades neural circuit performance. While there are biophysical mechanisms that can increase reliability, for instance by increasing vesicle release probability, these mechanisms cost energy. We examined four such mechanisms along with the associated scaling of the energetic costs. We then embedded these energetic costs for reliability in artificial neural networks (ANNs) with trainable stochastic synapses, and trained these networks on standard image classification tasks. The resulting networks revealed a tradeoff between circuit performance and the energetic cost of synaptic reliability. Additionally, the optimised networks exhibited two testable predictions consistent with pre-existing experimental data. Specifically, synapses with lower variability tended to have (1) higher input firing rates and (2) lower learning rates. Surprisingly, these predictions also arise when synapse statistics are inferred through Bayesian inference. Indeed, we were able to find a formal, theoretical link between the performance-reliability cost tradeoff and Bayesian inference. This connection suggests two incompatible possibilities: evolution may have chanced upon a scheme for implementing Bayesian inference by optimising energy efficiency, or alternatively, energy-efficient synapses may display signatures of Bayesian inference without actually using Bayes to reason about uncertainty.

    1. Neuroscience
    Wenyu Tu, Samuel R Cramer, Nanyin Zhang
    Research Article

    Resting-state brain networks (RSNs) have been widely applied in health and disease, but the interpretation of RSNs in terms of the underlying neural activity is unclear. To address this fundamental question, we conducted simultaneous recordings of whole-brain resting-state functional magnetic resonance imaging (rsfMRI) and electrophysiology signals in two separate brain regions of rats. Our data reveal that for both recording sites, spatial maps derived from band-specific local field potential (LFP) power can account for up to 90% of the spatial variability in RSNs derived from rsfMRI signals. Surprisingly, the time series of LFP band power can only explain to a maximum of 35% of the temporal variance of the local rsfMRI time course from the same site. In addition, regressing out time series of LFP power from rsfMRI signals has minimal impact on the spatial patterns of rsfMRI-based RSNs. This disparity in the spatial and temporal relationships between resting-state electrophysiology and rsfMRI signals suggests that electrophysiological activity alone does not fully explain the effects observed in the rsfMRI signal, implying the existence of an rsfMRI component contributed by ‘electrophysiology-invisible’ signals. These findings offer a novel perspective on our understanding of RSN interpretation.